Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

PerkinElmer, Inc. (PKI)

133.26   2.26 (1.73%) 03-31 16:03
Open: 131.64 Pre. Close: 131
High: 133.6 Low: 130.96
Volume: 589,316 Market Cap: 16,846(M)

Technical analysis

as of: 2023-03-31 4:21:18 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 156.04     One year: 182.26
Support: Support1: 123.18    Support2: 116.75
Resistance: Resistance1: 133.6    Resistance2: 156.04
Pivot: 126.11
Moving Average: MA(5): 129.98     MA(20): 125.64
MA(100): 134.31     MA(250): 138.88
MACD: MACD(12,26): 0.2     Signal(9): -1.1
Stochastic oscillator: %K(14,3): 95.1     %D(3): 91.9
RSI: RSI(14): 61.9
52-week: High: 174.1  Low: 113.45
Average Vol(K): 3-Month: 860 (K)  10-Days: 632 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PKI ] has closed Bollinger Bands are 2.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 133.68 - 134.08 134.08 - 134.52
Low: 130.09 - 130.57 130.57 - 131.12
Close: 132.4 - 133.14 133.14 - 133.96

Company Description

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Headline News

Sat, 01 Apr 2023
Maxwell Krakowiak Sells 322 Shares of PerkinElmer, Inc. (NYSE:PKI ... - MarketBeat

Wed, 29 Mar 2023
PerkinElmer Inc. stock rises Wednesday, still underperforms market - MarketWatch

Mon, 27 Mar 2023
Should You Sell PerkinElmer, Inc. (PKI) Stock Monday? - InvestorsObserver

Tue, 21 Mar 2023
Will PerkinElmer, Inc. (PKI) Stay at the Bottom of the Healthcare Sector? - InvestorsObserver

Thu, 16 Mar 2023
PerkinElmer, Inc. (NYSE:PKI) Receives Average Rating of "Hold ... - MarketBeat

Wed, 15 Mar 2023
Is PerkinElmer, Inc. (PKI) a Stock to Watch After Losing -1.34% This Week? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 126 (M)
Shares Float 116 (M)
% Held by Insiders 0.2 (%)
% Held by Institutions 85.6 (%)
Shares Short 3,480 (K)
Shares Short P.Month 3,070 (K)

Stock Financials

EPS 4.05
EPS Est Next Qtl 0.93
EPS Est This Year 2.88
EPS Est Next Year 3.26
Book Value (p.s.) 58.45
Profit Margin (%) 17.1
Operating Margin (%) 25.9
Return on Assets (ttm) 3.6
Return on Equity (ttm) 7
Qtrly Rev. Growth -27.9
Gross Profit (p.s.) 16.13
Sales Per Share 26.18
EBITDA (p.s.) 10.2
Qtrly Earnings Growth -32.5
Operating Cash Flow 680 (M)
Levered Free Cash Flow -262 (M)

Stock Valuations

PE Ratio 32.82
PEG Ratio -3
Price to Book value 2.27
Price to Sales 5.08
Price to Cash Flow 24.77

Stock Dividends

Dividend 0.07
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-02-10
Ex-Dividend Date 2022-01-19
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.